What to Know About COVID-19 Vaccines for Kids
News releases, Moderna: “Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population,” “Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents.”
Clinical Trials.gov: “Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals.”
Tina Tan, MD, pediatric infectious disease specialist, Ann & Robert H. Lurie Children’s Hospital, Chicago; professor of pediatrics, Feinberg School of Medicine, Northwestern University.
Sean O’Leary, MD, professor of pediatrics, University of Colorado Anschutz Medical Campus; vice chair, American Academy of Pediatrics Committee on Infectious Diseases.
Yvonne Maldonado, MD, chair, American Academy of Pediatrics Committee on Infectious Diseases; chief of pediatric infectious diseases, Stanford University School of Medicine, Stanford, CA.
American Academy of Pediatrics: “Children and COVID-19: State Level Data Report.”
Medrxiv.org: “SARS-CoV-2 antibodies detected in human breast milk post-vaccination,” “Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination.”
Source link